medigraphic.com
Colegio de Medicina Interna de México.

2018, Number 4

<< Back Next >>

Med Int Mex 2018; 34 (4)

Differences in the epicardial fat thickness in patients with diabetes mellitus 2, prediabetes and nondiabetic subjects

Arana-Pazos KC, Benítez-Maldonado DR, Meneses-Acero I, Narváez-Rivera JL, Guerrero-García C, Rubio-Guerra AF

Language: Spanish
References: 13
Page: 561-565
PDF size: 231.01 Kb.


ABSTRACT

Objective: To evaluate the differences in epicardial fat thickness in subjects with type-2 diabetes, prediabetes or non-diabetic.
Material and Method: A study was done from January to August 2017 evaluating subjects divided into 3 groups: group with type-2 diabetic patients, group with subjects with prediabetes and group with nondiabetic subjects. In all of them the epicardial fat thickness was measured with an Aloka alfa 6 equipment, by 2 cardiologists who were unaware of the clinical data. Statistical analysis was performed with ANOVA.
Results: There were included 120 patients divided into three groups of 40 patients each. Epicardial fat thickness was of 5.63 mm in diabetes mellitus group, 4.43 mm in prediabetes group and 4 mm in nondiabetic group. We did not find difference in epicardial fat thickness between nondiabetes and prediabetes groups (p = 0.09). However, we found significantly differences in epicardial fat thickness between diabetes group and groups of prediabetes and nondiabetes (p = 0.00017).
Conclusion: Type-2 diabetic patients have greater nondiabetes than prediabetic and nondiabetic subjects; this fact supports the relationship between visceral fat and the risk of type-2 diabetes.


REFERENCES

  1. Fernández-Muñoz MJ, Basurto-Acevedo L, Córdova-Pérez N, Vázquez Martínez AL, Tepach Gutiérrez N, Vega García S, et al. La grasa epicárdica se relaciona con la visceral, el síndrome metabólico y la resistencia a la insulina en mujeres menopáusicas. Rev Esp Cardiol 2014;67:436-41.

  2. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 2015;11:363-371.

  3. Laforest S, Labrecque J, Michaud A, Cianflone K, Tchernof A. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Crit Rev Clin Lab Sci 2015;52:301-13.

  4. Calabuig Á, Barba J, Guembe MJ, Díez J, Berjón J, Martínez- Vila E, et al. Grasa epicárdica en la población general de mediana edad y su asociación con el síndrome metabólico. Rev Esp Cardiol 2017. http://dx.doi.org/10.1016/j. recesp.2016.07.025

  5. Yerramasu A, Dey D, Venuraju S, Anand DV, Atwal S, Corder R, et al. Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis 2012;220:223-30.

  6. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003;11:304-10.

  7. Narváez-Rivera JL, Benítez-Maldonado DR, Mondragón-Gil Nayeli S, López-Ramírez SE, Ríos Flores L, Rubio-Guerra AF, et al. Association between epicardial fat, metabolic syndrome and obesity. J Diabetes Obes 2015;2:1-3.

  8. Kang J, Kim YC, Park JJ, et al. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins. Cardiovasc Diabetol. 2018;17:10.

  9. Iacobellis G. Epicardial adipose tissue in endocrine and metabolic diseases. Endocrine 2014;46:8-15.

  10. Yañez-Rivera TG, Baños-Gonzalez MA, Ble-Castillo JL, Torres-Hernandez ME, Torres-Lopez JE, Borrayo-Sanchez G. Relationship between epicardial adipose tissue, coronary artery disease and adiponectin in a Mexican population. Cardiovasc Ultrasound 2014 Sep 8;12:35.

  11. Rubio-Guerra AF, Benítez-Maldonado DR, Lozano-Nuevo JJ, Arana-Pazos KC, Huerta-Ramirez S, Narváez-Rivera JL. Correlación entre el grosor de la grasa epicárdica con marcadores bioquímicos de riesgo metabólico. Med Clin 2018; en prensa.

  12. Tachibana M, Miyoshi T, Osawa K, Toh N, Oe H, Nakamura K, et al. Measurement of epicardial fat thickness by transthoracic echocardiography for predicting high-risk coronary artery plaques. Heart V essels 2016 No v;31:1758-1766.

  13. Greulich S, Maxhera B, Vandenplas G, Herzfeld de Wiza D, Smiris K, Mueller H, et al. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation 2012;126:2324-34.




2020     |     www.medigraphic.com